The major objective of this grant proposal is to understand how HIV-1 infects cells. Entry of HIV-1 into target cells requires the binding of the virus to its cellular receptor, the CD4 glycoprotein, followed by fusion of the virion and cellular membranes and release of the viral core into the cytoplasm. Both the binding and fusion processes have been shown to be mediated by the envelope glycoprotein. Considerable details on the initial interaction of envelope gpl20 and CD4 have been reported, but the subsequent steps leading to membrane fusion are still poorly understood. Recent data indicate that the V3 hypervariable region of gpl2O is involved in these post-binding processes, and that sequences within this domain determine HIV-1 infectivity, host range and syncytium-forming ability. However, other regions of the envelope glycoprotein have also been found to affect these biological properties of HIV-1. Furthermore, the mechanism by which the V3 loop mediates viral entry, and what other cellular component(s) interacts with V3 in determining viral entry and tropism are still unknown.
Three specific aims are proposed to address these questions. First, with the use of recombinant and mutant viruses, we will continue our structure/function analyses of the HIV-1 genome to identify functional domains that interact with V3 to determine the replicative, host range and cytopathic properties of HIV-1. Second, we will test the hypothesis that the amino acid composition of the V3 loop influences the conformational changes in envelope glycoprotein that are induced by gpl2O/CD4 binding. We will monitor these conformational changes by determining the differential binding of MAb to wild-type and mutant virion or cell surface gpl2O, the differences in proteolytic digestion of wild-type and mutant virion gpl2O, and the differences in sensitivity to serum neutralization of wild-type and mutant viruses. Finally, by gene transfer experiments, we will attempt to identify the accessory cellular factor(s) that appears to be required for viral entry. An understanding of the mechanism by which HIV-1 infects cells, and the cellular factor(s) involved, may lead to the identification of new targets for anti-viral and vaccine developments.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
2R01AI029857-04
Application #
3144800
Study Section
AIDS and Related Research Study Section 1 (ARRA)
Project Start
1990-04-01
Project End
1996-03-31
Budget Start
1993-04-01
Budget End
1994-03-31
Support Year
4
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Stamatatos, L; Zolla-Pazner, S; Gorny, M K et al. (1997) Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells. Virology 229:360-9
Koito, A; Stamatatos, L; Cheng-Mayer, C (1995) Small amino acid sequence changes within the V2 domain can affect the function of a T-cell line-tropic human immunodeficiency virus type 1 envelope gp120. Virology 206:878-84
Harrowe, G; Cheng-Mayer, C (1995) Amino acid substitutions in the V3 loop are responsible for adaptation to growth in transformed T-cell lines of a primary human immunodeficiency virus type 1. Virology 210:490-4
Stamatatos, L; Cheng-Mayer, C (1995) Structural modulations of the envelope gp120 glycoprotein of human immunodeficiency virus type 1 upon oligomerization and differential V3 loop epitope exposure of isolates displaying distinct tropism upon virion-soluble receptor binding. J Virol 69:6191-8
Koito, A; Harrowe, G; Levy, J A et al. (1994) Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization. J Virol 68:2253-9
Stamatatos, L; Werner, A; Cheng-Mayer, C (1994) Differential regulation of cellular tropism and sensitivity to soluble CD4 neutralization by the envelope gp120 of human immunodeficiency virus type 1. J Virol 68:4973-9
LeGuern, M; Shioda, T; Levy, J A et al. (1993) Single amino acid change in Tat determines the different rates of replication of two sequential HIV-1 isolates. Virology 195:441-7
Stamatatos, L; Cheng-Mayer, C (1993) Evidence that the structural conformation of envelope gp120 affects human immunodeficiency virus type 1 infectivity, host range, and syncytium-forming ability. J Virol 67:5635-9
Cheng-Mayer, C; Shioda, T; Levy, J A (1991) Host range, replicative, and cytopathic properties of human immunodeficiency virus type 1 are determined by very few amino acid changes in tat and gp120. J Virol 65:6931-41
Liu, Z Q; Wood, C; Levy, J A et al. (1990) The viral envelope gene is involved in macrophage tropism of a human immunodeficiency virus type 1 strain isolated from brain tissue. J Virol 64:6148-53